Wang, X., Wang, X., Hodgson, L., George, S. L., Sargent, D. J., Foster, N. R., . . . Pang, H. (2017). Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials. Oncologist.
शिकागो स्टाइल उद्धरणWang, Xiaofei, et al. "Validation of Progression‐Free Survival As a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 2017.
एमएलए उद्धरणWang, Xiaofei, et al. "Validation of Progression‐Free Survival As a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 2017.